Roger Guillemin - Publications

Affiliations: 
1953-1970 Physiology Baylor College of Medicine, Houston, TX 
 1960-1963 Collège de France, Paris, Île-de-France, France 
 1970-1989 Neuroendocrinology Salk Institute for Biological Studies, La Jolla, CA, United States 
Area:
Neuroendocrinology
Website:
http://www.nobelprize.org/nobel_prizes/medicine/laureates/1977/guillemin-bio.html

216 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Guillemin R. A conversation with Roger Guillemin. Interview by Greg Lemke. Annual Review of Physiology. 75: 1-22. PMID 23398151 DOI: 10.1146/annurev-physiol-082712-104641  0.362
2011 Guillemin R. Neuroendocrinology: a short historical review. Annals of the New York Academy of Sciences. 1220: 1-5. PMID 21388398 DOI: 10.1111/j.1749-6632.2010.05936.x  0.401
2008 Guillemin R, Perrin MH. Neuroendocrinology: past, present and future. Annales D'Endocrinologie. 69: 160. PMID 18407243 DOI: 10.1016/j.ando.2008.02.018  0.321
2008 Guillemin R. Somatostatin: the beginnings, 1972. Molecular and Cellular Endocrinology. 286: 3-4. PMID 18395969 DOI: 10.1016/j.mce.2008.02.025  0.478
2005 Guillemin R. Hypothalamic hormones a.k.a. hypothalamic releasing factors. The Journal of Endocrinology. 184: 11-28. PMID 15642779 DOI: 10.1677/joe.1.05883  0.446
2003 GUILLEMIN R, HEARN WR. ACTH release by in vitro pituitary; effect of pitressin and purified arginine-vasopressin. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 89: 365-7. PMID 13254762 DOI: 10.3181/00379727-89-21812  0.312
1998 WARD DN, WALBORG EF, LIPSCOMB HS, GUILLEMIN R. Fractionation and analysis of monkey pituitary glands for posterior lobe hormones. Acta Endocrinologica. 40: 283-9. PMID 14004927 DOI: 10.1530/acta.0.0400283  0.365
1996 GUILLEMIN R. HYPOTHALAMIC POLYPEPTIDES RELEASING PITUITARY HORMONES. Metabolism: Clinical and Experimental. 13: SUPPL:1206-10. PMID 14228767 DOI: 10.1016/S0026-0495(64)80037-8  0.431
1993 Guillemin R. Somatostatin: the early days. Digestion. 54: 3-6. PMID 8103012 DOI: 10.1159/000201066  0.376
1989 Cuevas P, Carceller F, Esteban A, Baird A, Guillemin R. Basic fibroblast growth factor (bFGF) enhances retinal ganglion cells’ survival and promotes axonal growth of rat transected optic nerve Acta Neurologica Scandinavica. 79: 263-263. DOI: 10.1111/J.1600-0404.1989.Tb03770.X  0.43
1988 Shimasaki S, Koga M, Esch F, Cooksey K, Mercado M, Koba A, Ueno N, Ying SY, Ling N, Guillemin R. Primary structure of the human follistatin precursor and its genomic organization. Proceedings of the National Academy of Sciences of the United States of America. 85: 4218-22. PMID 3380788 DOI: 10.1073/Pnas.85.12.4218  0.303
1988 Ling N, Ueno N, Ying SY, Esch F, Shimasaki S, Hotta M, Cuevas P, Guillemin R. Inhibins and activins. Vitamins and Hormones. 44: 1-46. PMID 3070928 DOI: 10.1016/S0083-6729(08)60692-5  0.395
1988 Baird A, Schubert D, Ling N, Guillemin R. Receptor- and heparin-binding domains of basic fibroblast growth factor. Proceedings of the National Academy of Sciences of the United States of America. 85: 2324-8. PMID 2832850 DOI: 10.1073/Pnas.85.7.2324  0.491
1987 Ueno N, Baird A, Esch F, Ling N, Guillemin R. Isolation and partial characterization of basic fibroblast growth factor from bovine testis. Molecular and Cellular Endocrinology. 49: 189-94. PMID 3556754 DOI: 10.1016/0303-7207(87)90212-7  0.491
1987 Cuevas P, Ying SY, Ling N, Ueno N, Esch F, Guillemin R, Healy D, Ta S. Immunohistochemical detection of inhibin in the gonad. Biochemical and Biophysical Research Communications. 142: 23-30. PMID 3545204 DOI: 10.1016/0006-291X(87)90446-3  0.338
1987 Esch FS, Shimasaki S, Mercado M, Cooksey K, Ling N, Ying S, Ueno N, Guillemin R. Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad. Molecular Endocrinology (Baltimore, Md.). 1: 849-55. PMID 3153465 DOI: 10.1210/mend-1-11-849  0.325
1987 Ying SY, Becker A, Swanson G, Tan P, Ling N, Esch F, Ueno N, Shimasaki S, Guillemin R. Follistatin specifically inhibits pituitary follicle stimulating hormone release in vitro. Biochemical and Biophysical Research Communications. 149: 133-9. PMID 3120723 DOI: 10.1016/0006-291X(87)91614-7  0.451
1987 Ueno N, Ling N, Ying SY, Esch F, Shimasaki S, Guillemin R. Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proceedings of the National Academy of Sciences of the United States of America. 84: 8282-6. PMID 3120188 DOI: 10.1073/Pnas.84.23.8282  0.403
1987 Ying SY, Czvik J, Becker A, Ling N, Ueno N, Guillemin R. Secretion of follicle-stimulating hormone and production of inhibin are reciprocally related. Proceedings of the National Academy of Sciences of the United States of America. 84: 4631-5. PMID 3110772 DOI: 10.1073/pnas.84.13.4631  0.383
1987 Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M, Guillemin R. Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin Obstetrical and Gynecological Survey. 42: 109-111. DOI: 10.1097/00006254-198702000-00015  0.369
1986 Ueno N, Baird A, Esch F, Shimasaki S, Ling N, Guillemin R. Purification and partial characterization of a mitogenic factor from bovine liver: structural homology with basic fibroblast growth factor. Regulatory Peptides. 16: 135-45. PMID 3809608 DOI: 10.1016/0167-0115(86)90057-1  0.501
1986 Ueno N, Baird A, Esch F, Ling N, Guillemin R. Isolation of an amino terminal extended form of basic fibroblast growth factor. Biochemical and Biophysical Research Communications. 138: 580-8. PMID 3741423 DOI: 10.1016/S0006-291X(86)80536-8  0.477
1986 Baird A, Esch F, Mormède P, Ueno N, Ling N, Böhlen P, Ying SY, Wehrenberg WB, Guillemin R. Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues. Recent Progress in Hormone Research. 42: 143-205. PMID 3526451 DOI: 10.1016/B978-0-12-571142-5.50008-2  0.481
1986 Walicke P, Cowan WM, Ueno N, Baird A, Guillemin R. Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proceedings of the National Academy of Sciences of the United States of America. 83: 3012-6. PMID 3458259 DOI: 10.1073/Pnas.83.9.3012  0.442
1986 Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M, Guillemin R. A homodimer of the beta-subunits of inhibin A stimulates the secretion of pituitary follicle stimulating hormone. Biochemical and Biophysical Research Communications. 138: 1129-37. PMID 3092817 DOI: 10.1016/S0006-291X(86)80400-4  0.408
1986 Ying SY, Becker A, Ling N, Ueno N, Guillemin R. Inhibin and beta type transforming growth factor (TGF beta) have opposite modulating effects on the follicle stimulating hormone (FSH)-induced aromatase activity of cultured rat granulosa cells. Biochemical and Biophysical Research Communications. 136: 969-75. PMID 3087350 DOI: 10.1016/0006-291X(86)90427-4  0.384
1986 Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M, Guillemin R. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature. 321: 779-82. PMID 3086749 DOI: 10.1038/321779a0  0.415
1986 Ying SY, Becker A, Baird A, Ling N, Ueno N, Esch F, Guillemin R. Type beta transforming growth factor (TGF-beta) is a potent stimulator of the basal secretion of follicle stimulating hormone (FSH) in a pituitary monolayer system. Biochemical and Biophysical Research Communications. 135: 950-6. PMID 3083816 DOI: 10.1016/0006-291X(86)91020-X  0.545
1986 Bloch B, Baird A, Ling N, Guillemin R. Immunohistochemical evidence that growth hormone-releasing factor (GRF) neurons contain an amidated peptide derived from cleavage of the carboxyl-terminal end of the GRF precursor. Endocrinology. 118: 156-62. PMID 3079700 DOI: 10.1210/Endo-118-1-156  0.52
1986 Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proceedings of the National Academy of Sciences of the United States of America. 83: 7297-301. PMID 2429303 DOI: 10.1073/Pnas.83.19.7297  0.449
1985 Esch F, Ueno N, Baird A, Hill F, Denoroy L, Ling N, Gospodarowicz D, Guillemin R. Primary structure of bovine brain acidic fibroblast growth factor (FGF). Biochemical and Biophysical Research Communications. 133: 554-62. PMID 4084288 DOI: 10.1016/0006-291X(85)90942-8  0.478
1985 Baird A, Böhlen P, Ling N, Guillemin R. Radioimmunoassay for fibroblast growth factor (FGF): release by the bovine anterior pituitary in vitro. Regulatory Peptides. 10: 309-17. PMID 4039829 DOI: 10.1016/0167-0115(85)90043-6  0.544
1985 Baird A, Mormède P, Ying SY, Wehrenberg WB, Ueno N, Ling N, Guillemin R. A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotropin and prolactin secretion. Proceedings of the National Academy of Sciences of the United States of America. 82: 5545-9. PMID 3927303 DOI: 10.1073/Pnas.82.16.5545  0.568
1985 Baird A, Esch F, Gospodarowicz D, Guillemin R. Retina- and eye-derived endothelial cell growth factors: partial molecular characterization and identity with acidic and basic fibroblast growth factors. Biochemistry. 24: 7855-60. PMID 3912009 DOI: 10.1021/Bi00348A001  0.475
1985 Ling N, Ying SY, Ueno N, Esch F, Denoroy L, Guillemin R. Isolation and partial characterization of a Mr 32,000 protein with inhibin activity from porcine follicular fluid. Proceedings of the National Academy of Sciences of the United States of America. 82: 7217-21. PMID 3864157 DOI: 10.1073/pnas.82.21.7217  0.322
1985 Esch F, Baird A, Ling N, Ueno N, Hill F, Denoroy L, Klepper R, Gospodarowicz D, Böhlen P, Guillemin R. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proceedings of the National Academy of Sciences of the United States of America. 82: 6507-11. PMID 3863109 DOI: 10.1073/Pnas.82.19.6507  0.485
1985 Ling N, Zeytin F, Böhlen P, Esch F, Brazeau P, Wehrenberg WB, Baird A, Guillemin R. Growth hormone releasing factors. Annual Review of Biochemistry. 54: 403-23. PMID 2992358 DOI: 10.1146/Annurev.Bi.54.070185.002155  0.528
1985 Benoit R, Bohlen P, Ling N, Esch F, Baird A, Ying SY, Wehrenberg WB, Guillemin R, Morrison JH, Bakhit C. Somatostatin-28 [1-12]-like peptides. Advances in Experimental Medicine and Biology. 188: 89-107. PMID 2863951 DOI: 10.1007/978-1-4615-7886-4_6  0.526
1985 Wehrenberg WB, Baird A, Zeytin F, Esch F, Böhlen P, Ling N, Ying SY, Guillemin R. Physiological studies with somatocrinin, a growth hormone-releasing factor. Annual Review of Pharmacology and Toxicology. 25: 463-83. PMID 2860847 DOI: 10.1146/annurev.pa.25.040185.002335  0.485
1985 Mason AJ, Hayflick JS, Ling N, Esch F, Ueno N, Ying SY, Guillemin R, Niall H, Seeburg PH. Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta. Nature. 318: 659-63. PMID 2417121 DOI: 10.1038/318659a0  0.373
1985 Baird A, Culler F, Jones KL, Guillemin R. Angiogenic factor in human ocular fluid. Lancet (London, England). 2: 563. PMID 2412079 DOI: 10.1016/S0140-6736(85)90512-4  0.41
1984 Böhlen P, Wehrenberg WB, Esch F, Ling N, Brazeau P, Guillemin R. Rat hypothalamic growth hormone-releasing factor: isolation, sequence analysis and total synthesis. Biochemical and Biophysical Research Communications. 125: 1005-12. PMID 6440563 DOI: 10.1016/0006-291X(84)91383-4  0.384
1984 Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg WB, Guillemin R. Growth hormone-releasing factor from ovine and caprine hypothalamus: isolation, sequence analysis and total synthesis. Biochemical and Biophysical Research Communications. 125: 606-14. PMID 6440561 DOI: 10.1016/0006-291X(84)90582-5  0.402
1984 Ling N, Esch F, Böhlen P, Brazeau P, Wehrenberg WB, Guillemin R. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proceedings of the National Academy of Sciences of the United States of America. 81: 4302-6. PMID 6431406 DOI: 10.1073/Pnas.81.14.4302  0.398
1984 Bloch B, Ling N, Benoit R, Wehrenberg WB, Guillemin R. Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence. Nature. 307: 272-3. PMID 6420704 DOI: 10.1038/307272a0  0.382
1984 Esch F, Ling N, Bohlen P, Baird A, Benoit R, Guillemin R. Isolation and characterization of the bovine hypothalamic corticotropin-releasing factor. Biochemical and Biophysical Research Communications. 122: 899-905. PMID 6332625 DOI: 10.1016/0006-291X(84)91175-6  0.481
1984 Ling N, Esch F, Böhlen P, Baird A, Guillemin R. Isolation and characterization of caprine corticotropin-releasing factor. Biochemical and Biophysical Research Communications. 122: 1218-24. PMID 6332624 DOI: 10.1016/0006-291X(84)91222-1  0.482
1984 Wehrenberg WB, Baird A, Ying SY, Rivier C, Ling N, Guillemin R. Multiple stimulation of the adenohypophysis by combinations of hypothalamic releasing factors. Endocrinology. 114: 1995-2001. PMID 6327231 DOI: 10.1210/Endo-114-6-1995  0.664
1984 Guillemin R, Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg WB, Bloch B, Mougin C, Zeytin F, Baird A. Somatocrinin, the growth hormone releasing factor. Recent Progress in Hormone Research. 40: 233-99. PMID 6148773 DOI: 10.1016/B978-0-12-571140-1.50011-6  0.491
1984 Wehrenberg WB, Bloch B, Chong-Li Z, Brazeau P, Ling N, Guillemin R. Pituitary response to growth hormone-releasing factor in rats with functional or anatomical lesions of the central nervous system that inhibit endogenous growth hormone secretion. Regulatory Peptides. 8: 1-8. PMID 6144144 DOI: 10.1016/0167-0115(84)90023-5  0.355
1984 Wehrenberg WB, Brazeau P, Ling N, Textor G, Guillemin R. Pituitary growth hormone response in rats during a 24-hour infusion of growth hormone-releasing factor. Endocrinology. 114: 1613-6. PMID 6143658 DOI: 10.1210/endo-114-5-1613  0.372
1983 Esch F, Böhlen P, Ling N, Brazeau P, Guillemin R. Isolation and characterization of the bovine hypothalamic growth hormone releasing factor. Biochemical and Biophysical Research Communications. 117: 772-9. PMID 6421287 DOI: 10.1016/0006-291X(83)91664-9  0.416
1983 Böhlen P, Esch F, Brazeau P, Ling N, Guillemin R. Isolation and characterization of the porcine hypothalamic growth hormone releasing factor. Biochemical and Biophysical Research Communications. 116: 726-34. PMID 6418166 DOI: 10.1016/0006-291X(83)90585-5  0.413
1983 Böhlen P, Brazeau P, Bloch B, Ling N, Gaillard R, Guillemin R. Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40. Biochemical and Biophysical Research Communications. 114: 930-6. PMID 6412708 DOI: 10.1016/0006-291X(83)90649-6  0.392
1983 Wehrenberg WB, Benoit R, Baird A, Guillemin R. Inhibitory effects of cysteamine on neuroendocrine function. Regulatory Peptides. 6: 137-45. PMID 6410461 DOI: 10.1016/0167-0115(83)90006-X  0.56
1983 Rosenthal SM, Schriock EA, Kaplan SL, Guillemin R, Grumbach MM. Synthetic human pancreas growth hormone-releasing factor (hpGRF1-44-NH2) stimulates growth hormone secretion in normal men. The Journal of Clinical Endocrinology and Metabolism. 57: 677-9. PMID 6409919 DOI: 10.1210/jcem-57-3-677  0.414
1983 Bloch B, Brazeau P, Ling N, Bohlen P, Esch F, Wehrenberg WB, Benoit R, Bloom F, Guillemin R. Immunohistochemical detection of growth hormone-releasing factor in brain. Nature. 301: 607-8. PMID 6402707 DOI: 10.1038/301607a0  0.604
1983 Bloch B, Baird A, Ling N, Benoit R, Guillemin R. Immunohistochemical evidence that brain enkephalins arise from a precursor similar to adrenal preproenkephalin. Brain Research. 263: 251-7. PMID 6340794 DOI: 10.1016/0006-8993(83)90317-7  0.483
1983 Böhlen P, Brazeau P, Esch F, Ling N, Wehrenberg WB, Guillemin R. Human growth hormone releasing factor and somatostatin from two pancreatic tumors: isolation and characterization. Regulatory Peptides. 6: 343-53. PMID 6138818 DOI: 10.1016/0167-0115(83)90263-X  0.427
1983 Wehrenberg WB, Brazeau P, Luben R, Ling N, Guillemin R. A noninvasive functional lesion of the hypothalamo-pituitary axis for the study of growth hormone-releasing factor. Neuroendocrinology. 36: 489-91. PMID 6136006 DOI: 10.1159/000123504  0.442
1983 Antoni FA, Palkovits M, Makara GB, Linton EA, Lowry PJ, Kiss JZ, Bugajski J, Gą A, dek, Walker RF, Luine VN, McEwen BS, Wehrenberg WB, Brazeau P, Luben R, ... ... Guillemin R, et al. Subject Index Vol. 36, 1983 Neuroendocrinology. 36: 495-496. DOI: 10.1159/000123507  0.344
1983 Antoni FA, Palkovits M, Makara GB, Linton EA, Lowry PJ, Kiss JZ, Bugajski J, Gą A, dek, Walker RF, Luine VN, McEwen BS, Wehrenberg WB, Brazeau P, Luben R, ... ... Guillemin R, et al. Contents, Vol. 36, 1983 Neuroendocrinology. 36. DOI: 10.1159/000123490  0.365
1982 Esch FS, Böhlen P, Ling NC, Brazeau PE, Wehrenberg WB, Thorner MO, Cronin MJ, Guillemin R. Characterization of a 40 residue peptide from a human pancreatic tumor with growth hormone releasing activity. Biochemical and Biophysical Research Communications. 109: 152-8. PMID 7159418 DOI: 10.1016/0006-291X(82)91578-9  0.393
1982 Benoit R, Ling N, Bakhit C, Morrison JH, Alford B, Guillemin R. Somatostatin-28(1-12)-like immunoreactivity in the rat. Endocrinology. 111: 2149-51. PMID 7140652 DOI: 10.1210/endo-111-6-2149  0.341
1982 Baird A, Ling N, Böhlen P, Benoit R, Klepper R, Guillemin R. Molecular forms of the putative enkephalin precursor BAM-12P in bovine adrenal, pituitary, and hypothalamus. Proceedings of the National Academy of Sciences of the United States of America. 79: 2023-5. PMID 6952250 DOI: 10.1073/Pnas.79.6.2023  0.47
1982 Wehrenberg WB, Ling N, Brazeau P, Esch F, Böhlen P, Baird A, Ying S, Guillemin R. Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized rats. Biochemical and Biophysical Research Communications. 109: 382-7. PMID 6817757 DOI: 10.1016/0006-291X(82)91732-6  0.588
1982 Luben RA, Brazeau P, Böhlen P, Guillemin R. Monoclonal antibodies to hypothalamic growth hormone-releasing factor with picomoles of antigen. Science (New York, N.Y.). 218: 887-9. PMID 6813967 DOI: 10.1126/Science.6813967  0.37
1982 Guillemin R, Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg WB. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science (New York, N.Y.). 218: 585-7. PMID 6812220 DOI: 10.1126/science.6812220  0.421
1982 Brazeau P, Ling N, Esch F, Böhlen P, Mougin C, Guillemin R. Somatocrinin (growth hormone releasing factor) in vitro bioactivity; Ca++ involvement, cAMP mediated action and additivity of effect with PGE2. Biochemical and Biophysical Research Communications. 109: 588-94. PMID 6185122 DOI: 10.1016/0006-291X(82)91762-4  0.416
1982 Brazeau P, Ling N, Böhlen P, Esch F, Ying SY, Guillemin R. Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro. Proceedings of the National Academy of Sciences of the United States of America. 79: 7909-13. PMID 6130528 DOI: 10.1073/pnas.79.24.7909  0.442
1982 Wehrenberg WB, Ling N, Böhlen P, Esch F, Brazeau P, Guillemin R. Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion. Biochemical and Biophysical Research Communications. 109: 562-7. PMID 6129852 DOI: 10.1016/0006-291X(82)91758-2  0.396
1982 Wehrenberg WB, Brazeau P, Luben R, Böhlen P, Guillemin R. Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF). Endocrinology. 111: 2147-8. PMID 6128220 DOI: 10.1210/Endo-111-6-2147  0.413
1982 Benoit R, Ling N, Alford B, Guillemin R. Seven peptides derived from pro-somatostatin in rat brain. Biochemical and Biophysical Research Communications. 107: 944-50. PMID 6127997 DOI: 10.1016/0006-291X(82)90614-3  0.379
1982 Benoit R, Böhlen P, Ling N, Briskin A, Esch F, Brazeau P, Ying SY, Guillemin R. Presence of somatostatin-28-(1-12) in hypothalamus and pancreas. Proceedings of the National Academy of Sciences of the United States of America. 79: 917-21. PMID 6121326 DOI: 10.1073/Pnas.79.3.917  0.359
1981 Böhlen P, Esch F, Shibasaki T, Baird A, Ling N, Guillemin R. Isolation and characterization of a gamma 1-melanotropin-like peptide from bovine neurointermediate pituitary. Febs Letters. 128: 67-70. PMID 7274457 DOI: 10.1016/0014-5793(81)81081-2  0.514
1981 Shibasaki T, Ling N, Guillemin R, Silver M, Bloom F. The regional distribution of gamma 3-melanotropin-like peptides in bovine brain is correlated with adrenocorticotropin immunoreactivity but not with beta-endorphin. Regulatory Peptides. 2: 43-52. PMID 6262881 DOI: 10.1016/0167-0115(81)90064-1  0.526
1981 Shibasaki T, Masui H, Sato G, Ling N, Guillemin R. Secretion pattern of pro-opiomelanocortin-derived peptides by a pituitary adenoma from a patient with Cushing's disease. The Journal of Clinical Endocrinology and Metabolism. 52: 350-3. PMID 6257745 DOI: 10.1210/jcem-52-2-350  0.372
1981 Ying SY, Ling N, Böhlen P, Guillemin R. Gonadocrinins: peptides in ovarian follicular fluid stimulating the secretion of pituitary gonadotropins. Endocrinology. 108: 1206-15. PMID 6162633 DOI: 10.1210/endo-108-4-1206  0.429
1981 Böhlen P, Brazeau P, Esch F, Ling N, Guillemin R. Isolation and chemical characterization of somatostatin-28 from rat hypothalamus. Regulatory Peptides. 2: 359-69. PMID 6117931 DOI: 10.1016/0167-0115(81)90018-5  0.361
1981 Brazeau P, Ling N, Esch F, Böhlen P, Benoit R, Guillemin R. High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25. Regulatory Peptides. 1: 255-64. PMID 6114516 DOI: 10.1016/0167-0115(81)90048-3  0.413
1981 Mandarino L, Stenner D, Blanchard W, Nissen S, Gerich J, Ling N, Brazeau P, Bohlen P, Esch F, Guillemin R. Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion. Nature. 291: 76-7. PMID 6112710 DOI: 10.1038/291076A0  0.437
1980 Shibasaki T, Ling N, Guillemin R. A radioimmunoassay for gamma 1-melanotropin and evidence that the smallest pituitary gamma-melanotropin is amidated at the COOH-terminus. Biochemical and Biophysical Research Communications. 96: 1393-9. PMID 7437077 DOI: 10.1016/0006-291X(80)90105-9  0.326
1980 Jackson IM, Bolaffi JL, Guillemin R. Presence of immunoreactive beta-endorphin and enkephalin-like material in the retina and other tissues of the frog, Rana pipiens. General and Comparative Endocrinology. 42: 505-8. PMID 6970153 DOI: 10.1016/0016-6480(80)90217-8  0.323
1980 Bloom FE, Battenberg EL, Shibasaki T, Benoit R, Ling N, Guillemin R. Localization of gamma-melanocyte stimulating hormone (gamma MSH) immunoreactivity in rat brain and pituitary. Regulatory Peptides. 1: 205-22. PMID 6262877 DOI: 10.1016/0167-0115(80)90272-4  0.54
1980 Rossier J, French E, Guillemin R, Bloom FE. On the mechanisms of the simultaneous release of immunoreactive beta-endorphin, ACTH, and prolactin by stress. Advances in Biochemical Psychopharmacology. 22: 363-75. PMID 6249081  0.505
1980 Shibasaki T, Ling N, Guillemin R. A radioimmunoassay for gamma-melanocyte stimulating hormone. Life Sciences. 26: 1781-5. PMID 6248714 DOI: 10.1016/0024-3205(80)90578-0  0.34
1980 Rossier J, French E, Rivier C, Shibasaki T, Guillemin R, Bloom FE. Stress-induced release of prolactin: blockade by dexamethasone and naloxone may indicate beta-endorphin mediation. Proceedings of the National Academy of Sciences of the United States of America. 77: 666-9. PMID 6244573 DOI: 10.1073/Pnas.77.1.666  0.715
1980 Esch F, Böhlen P, Ling N, Benoit R, Brazeau P, Guillemin R. Primary structure of ovine hypothalamic somatostatin-28 and somatostatin-25. Proceedings of the National Academy of Sciences of the United States of America. 77: 6827-31. PMID 6109284 DOI: 10.1073/Pnas.77.11.6827  0.345
1980 Benoit R, Böhlen P, Brazeau P, Ling N, Guillemin R. Isolation and characterization of rat pancreatic somatostatin. Endocrinology. 107: 2127-9. PMID 6107246 DOI: 10.1210/endo-107-6-2127  0.346
1980 Böhlen P, Brazeau P, Benoit R, Ling N, Esch F, Guillemin R. Isolation and amino acid composition of two somatostatin-like peptides from ovine hypothalamus: somatostatin-28 and somatostatin-25. Biochemical and Biophysical Research Communications. 96: 725-34. PMID 6107078 DOI: 10.1016/0006-291X(80)91415-1  0.337
1980 Ling N, Esch F, Davis D, Mercado M, Regno M, Bohlen P, Brazeau P, Guillemin R. Solid phase synthesis of somatostatin-28. Biochemical and Biophysical Research Communications. 95: 945-51. PMID 6106480 DOI: 10.1016/0006-291X(80)91564-8  0.324
1980 Rossier J, Pittman Q, Bloom F, Guillemin R. Distribution of opioid peptides in the pituitary: a new hypothalamic-pars nervosa enkephalinergic pathway. Federation Proceedings. 39: 2555-60. PMID 6103825  0.487
1980 Shibasaki T, Ling N, Guillemin R. Pituitary immunoreactive gamma-melanotropins are glycosylated oligopeptides. Nature. 285: 416-7. PMID 6101229 DOI: 10.1038/285416A0  0.386
1979 Rossier J, French E, Gros C, Minick S, Guillemin R, Bloom FE. Adrenalectomy, dexamethasone or stress alters opioid peptides levels in rat anterior pituitary but not intermediate lobe or brain. Life Sciences. 25: 2105-12. PMID 537470 DOI: 10.1016/0024-3205(79)90204-2  0.627
1979 Lavielle S, Ling N, Brazeau P, Benoit R, Wasada T, Harris D, Unger R, Guillemin R. Synthesis and biological activity of glycosylated analogs of somatostatin. Biochemical and Biophysical Research Communications. 91: 614-22. PMID 518658 DOI: 10.1016/0006-291X(79)91566-3  0.368
1979 Bayon A, Shoemaker WJ, Bloom FE, Mauss A, Guillemin R. Perinatal development of the endorphin- and enkephalin-containing systems in the rat brain. Brain Research. 179: 93-101. PMID 509236 DOI: 10.1016/0006-8993(79)90493-1  0.485
1979 Chorev M, Shavitz R, Goodman M, Minick S, Guillemin R. Partially modified retro-inverso-enkephalinamides: topochemical long-acting analogs in vitro and in vivo. Science (New York, N.Y.). 204: 1210-2. PMID 451565 DOI: 10.1126/Science.451565  0.305
1979 Ying SY, Guillemin R. Dried Staphylococcus aureus as a rapid immunological separating agent in radioimmunoassays. The Journal of Clinical Endocrinology and Metabolism. 48: 360-2. PMID 429490 DOI: 10.1210/jcem-48-2-360  0.307
1979 Rossier J, Rogers J, Shibasaki T, Guillemin R, Bloom FE. Opioid peptides and alpha-melanocyte-stimulating hormone in genetically obese (ob/ob) mice during development. Proceedings of the National Academy of Sciences of the United States of America. 76: 2077-80. PMID 287046 DOI: 10.1073/Pnas.76.4.2077  0.588
1979 Ling N, Ying S, Minick S, Guillemin R. Synthesis and biological activity of four gamma-melanotropin peptides derived from the cryuptic region of the adrenocorticotropin/beta-lipotropin precursor. Life Sciences. 25: 1773-9. PMID 231164 DOI: 10.1016/0024-3205(79)90481-8  0.366
1979 Shibasaki T, Deftos L, Guillemin R. Immunoreactive-beta-endorphin, -adrenocorticotropin and -calcitonin in extracts of anaplastic or differentiated (rat) medullary thyroid carcinoma. Biochemical and Biophysical Research Communications. 90: 1266-73. PMID 229834 DOI: 10.1016/0006-291X(79)91173-2  0.332
1979 Ying SY, Guillemin R. DTrp6-Pro9-NEt)-luteinising hormone-releasing factor inhibits follicular development in hypophysectomised rats. Nature. 280: 593-5. PMID 223068 DOI: 10.1038/280593A0  0.441
1979 Ying SY, Guillemin R. [Gonadostatin and gonadocrinin, polypeptides of ovarian origin with hypophysiotropic activity]. Comptes Rendus Des SéAnces De L'AcadéMie Des Sciences. SéRie D, Sciences Naturelles. 289: 943-6. PMID 121254  0.327
1979 Hosobuchi Y, Rossier J, Bloom FE, Guillemin R. Stimulation of human periaqueductal gray for pain relief increases immunoreactive beta-endorphin in ventricular fluid. Science (New York, N.Y.). 203: 279-81. PMID 83674 DOI: 10.1126/Science.83674  0.615
1979 Rossier J, Battenberg E, Pittman Q, Bayon A, Koda L, Miller R, Guillemin R, Bloom F. Hypothalamic enkephalin neurones may regulate the neurohypophysis. Nature. 277: 653-5. PMID 34105 DOI: 10.1038/277653A0  0.617
1979 Bloom FE, Rossier J, Battenberg ELF, Bayon A, French ED, Henriksen SJ, Siggins GR, Ling N, Guillemin R. β-Endorphin: cellular localization, electrophysiological and behavioral effects Advances in Biochemical Psychopharmacology. 18: 17-29. DOI: 10.1007/978-1-349-04015-5_2  0.561
1978 Rossier J, Guillemin R, Bloom F. Foot shock induced stress decreases leu5-enkephalin immunoreactivity in rat hypothalamus. European Journal of Pharmacology. 48: 465-6. PMID 565718 DOI: 10.1016/0014-2999(78)90178-4  0.582
1978 Deftos LJ, Burton D, Catherwood BD, Bone HG, Parthemore JG, Guillemin R, Watkins WB, Moore RY. Demonstration by immunoperoxidase histochemistry of calcitonin in the anterior lobe of the rat pituitary. The Journal of Clinical Endocrinology and Metabolism. 47: 457-60. PMID 400721 DOI: 10.1210/jcem-47-2-457  0.34
1978 Bloom F, Battenberg E, Rossier J, Ling N, Guillemin R. Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies. Proceedings of the National Academy of Sciences of the United States of America. 75: 1591-5. PMID 349568 DOI: 10.1073/Pnas.75.3.1591  0.624
1978 Henriksen SJ, Bloom FE, McCoy F, Ling N, Guillemin R. beta-Endorphin induces nonconvulsive limbic seizures. Proceedings of the National Academy of Sciences of the United States of America. 75: 5221-5. PMID 283426 DOI: 10.1073/pnas.75.10.5221  0.507
1978 Bayon A, Rossier J, Mauss A, Bloom FE, Iversen LL, Ling N, Guillemin R. In vitro release of [5-methionine]enkephalin and [5-leucine]-enkephalin from the rat globus pallidus. Proceedings of the National Academy of Sciences of the United States of America. 75: 3503-6. PMID 277953 DOI: 10.1073/Pnas.75.7.3503  0.642
1978 Orth DN, Guillemin R, Ling N, Nicholson WE. Immunoreactive endorphins, lipotropins and corticotropins in a human nonpituitary tumor: evidence for a common precursor. The Journal of Clinical Endocrinology and Metabolism. 46: 849-52. PMID 233636 DOI: 10.1210/jcem-46-5-849  0.32
1978 Vale W, Rivier C, Yang L, Minick S, Guillemin R. Effects of purified hypothalamic corticotropin-releasing factor and other substances on the secretion of adrenocorticotropin and beta-endorphin-like immunoactivities in vitro. Endocrinology. 103: 1910-5. PMID 218793 DOI: 10.1210/endo-103-5-1910  0.652
1978 Bloom FE, Rossier J, Battenberg EL, Bayon A, French E, Henriksen SJ, Siggins GR, Segal D, Browne R, Ling N, Guillemin R. beta-endorphin: cellular localization, electrophysiological and behavioral effects. Advances in Biochemical Psychopharmacology. 18: 89-109. PMID 77124  0.411
1978 Guillemin R. Beta-lipotropin and endorphins: implications of current knowledge. Hospital Practice. 13: 53-60. PMID 33114 DOI: 10.1080/21548331.1978.11707431  0.392
1978 Iversen LL, Iversen SD, Bloom FE, Vargo T, Guillemin R. Release of enkephalin from rat globus pallidus in vitro. Nature. 271: 679-81. PMID 24182 DOI: 10.1038/271679A0  0.535
1978 Guillemin R, Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F. β-ENDORPHIN AND ADRENOCORTICOTROPIN ARE SECRETED CONCOMITANTLY BY THE PITUITARY GLAND Obstetrical & Gynecological Survey. 33: 184-185. DOI: 10.1097/00006254-197803000-00017  0.714
1977 Rossier J, Bayon A, Vargo TM, Ling N, Guillemin R, Bloom F. Radioimmunoassay of brain peptides: evaluation of a methodology for the assay of beta-endorphin and enkephalin. Life Sciences. 21: 847-52. PMID 916802 DOI: 10.1016/0024-3205(77)90414-3  0.608
1977 Segal DS, Browne RG, Bloom F, Ling N, Guillemin R. beta-Endorphin: endogenous opiate or neuroleptic? Science (New York, N.Y.). 198: 411-4. PMID 910136 DOI: 10.1126/science.910136  0.509
1977 Guillemin R, Ling N, Burgus R, Bloom F, Segal D. Characterization of the endorphins, novel hypothalamic and neurohypophysial peptides with opiate-like activity: evidence that they induce profound behavioral changes. Psychoneuroendocrinology. 2: 59-62. PMID 905475 DOI: 10.1016/0306-4530(77)90032-4  0.507
1977 Janowsky DS, Segal DS, Bloom F, Abrams A, Guillemin R. Lack of effect on naloxone on schizophrenic symptoms. The American Journal of Psychiatry. 134: 926-7. PMID 879360 DOI: 10.1176/ajp.134.8.926  0.317
1977 Guillemin R. Purification, isolation, and primary structure of the hypothalamic luteinizing hormone-releasing factor of ovine origin. A historical account. American Journal of Obstetrics and Gynecology. 129: 214-8. PMID 331955 DOI: 10.1016/0002-9378(77)90749-9  0.414
1977 Bloom F, Battenberg E, Rossier J, Ling N, Leppaluoto J, Vargo TM, Guillemin R. Endorphins are located in the intermediate and anterior lobes of the pituitary gland, not in the neurohypophysis. Life Sciences. 20: 43-7. PMID 319317 DOI: 10.1016/0024-3205(77)90126-6  0.624
1977 Guillemin R, Ling N, Lazarus L, Burgus R, Minick S, Bloom F, Nicoll R, Siggins G, Segal D. The endorphins, novel peptides of brain and hypophysial origin, with opiate-like activity: biochemical and biologic studies. Annals of the New York Academy of Sciences. 297: 131-57. PMID 279259 DOI: 10.1111/J.1749-6632.1977.Tb41850.X  0.495
1977 Rossier J, Vargo TM, Minick S, Ling N, Bloom FE, Guillemin R. Regional dissociation of beta-endorphin and enkephalin contents in rat brain and pituitary. Proceedings of the National Academy of Sciences of the United States of America. 74: 5162-5. PMID 270754 DOI: 10.1073/Pnas.74.11.5162  0.625
1977 Nicoll RA, Siggins GR, Ling N, Bloom FE, Guillemin R. Neuronal actions of endorphins and enkephalins among brain regions: a comparative microiontophoretic study. Proceedings of the National Academy of Sciences of the United States of America. 74: 2584-8. PMID 267951 DOI: 10.1073/Pnas.74.6.2584  0.515
1977 Rossier J, French ED, Rivier C, Ling N, Guillemin R, Bloom FE. Foot-shock induced stress increases beta-endorphin levels in blood but not brain. Nature. 270: 618-20. PMID 201864 DOI: 10.1038/270618A0  0.666
1977 Kan KW, Baird A, Seidah NG, Lis M, Chrétien M, Ling N, Guillemin R, Solomon S. Effects of peptides of pituitary origin on the formation of C21 steroid by fetal calf adrenal cells in culture. Biochemical and Biophysical Research Communications. 79: 553-60. PMID 201254 DOI: 10.1016/0006-291X(77)90193-0  0.46
1977 Guillemin R, Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F. beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. Science (New York, N.Y.). 197: 1367-9. PMID 197601 DOI: 10.1126/Science.197601  0.747
1977 Rivier C, Vale W, Ling N, Brown M, Guillemin R. Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin. Endocrinology. 100: 238-41. PMID 187406 DOI: 10.1210/endo-100-1-238  0.645
1977 Guillemin R. The endocrinology of the neuron and the neural origin of endocrine cells. Advances in Experimental Medicine and Biology. 87: 1-12. PMID 19951 DOI: 10.1007/978-1-4615-8849-8_1  0.318
1976 Ling N, Burgus R, Guillemin R. Isolation, primary structure, and synthesis of alpha-endorphin and gamma-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity. Proceedings of the National Academy of Sciences of the United States of America. 73: 3942-6. PMID 1069261 DOI: 10.1073/Pnas.73.11.3942  0.338
1976 Ling N, Guillemin R. Morphinomimetic activity of synthetic fragments of beta-lipotropin and analogs. Proceedings of the National Academy of Sciences of the United States of America. 73: 3308-10. PMID 1067621 DOI: 10.1073/Pnas.73.9.3308  0.31
1976 Lazarus LH, Ling N, Guillemin R. beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins. Proceedings of the National Academy of Sciences of the United States of America. 73: 2156-9. PMID 1064883 DOI: 10.1073/Pnas.73.6.2156  0.343
1976 Orci L, Baetens O, Rufener C, Brown M, Vale W, Guillemin R. Evidence for immunoreactive neurotensin in dog intestinal mucosa. Life Sciences. 19: 559-61. PMID 785139 DOI: 10.1016/0024-3205(76)90236-8  0.447
1976 Guillemin R, Gerich JE. Somatostatin: physiological and clinical significance. Annual Review of Medicine. 27: 379-88. PMID 779605 DOI: 10.1146/annurev.me.27.020176.002115  0.432
1976 Guillemin R. Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus. Endocrinology. 99: 1653-4. PMID 187417 DOI: 10.1210/endo-99-6-1653  0.33
1976 Bloom F, Segal D, Ling N, Guillemin R. Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. Science (New York, N.Y.). 194: 630-2. PMID 185694 DOI: 10.1126/Science.185694  0.533
1976 Guillemin R. The expanding significance of hypothalamic peptides, or, is endocrinology a branch of neuroendocrinology? Recent Progress in Hormone Research. 33: 1-28. PMID 20649 DOI: 10.1016/B978-0-12-571133-3.50008-8  0.34
1975 Vale W, Brazeau P, Rivier C, Brown M, Boss B, Rivier J, Burgus R, Ling N, Guillemin R. Somatostatin. Recent Progress in Hormone Research. 31: 365-97. PMID 1105719  0.543
1975 Rivier J, Brazeau P, Vale W, Guillemin R. Somatostatin analogs. Relative importance of the disulfide bridge and of the Ala-Gly side chain for biological activity. Journal of Medicinal Chemistry. 18: 123-6. PMID 1091734 DOI: 10.1002/Chin.197524427  0.429
1975 Brown M, Rivier J, Vale W, Guillemin R. Variability of the duration of inhibition of growth hormone release by Nalpha-acylated-des-(Ala1-Gly2)-H2somatostatin analogs. Biochemical and Biophysical Research Communications. 65: 752-6. PMID 807218 DOI: 10.1016/S0006-291X(75)80209-9  0.53
1974 Brazeau P, Rivier J, Vale W, Guillemin R. Inhibition of growth hormone secretion in the rat by synthetic somatostatin. Endocrinology. 94: 184-7. PMID 4808882 DOI: 10.1210/endo-94-1-184  0.504
1974 Brazeau P, Vale W, Burgus R, Guillemin R. Isolation of somatostatin (a somatotropin release inhibiting factor) of ovine hypothalamic origin. Canadian Journal of Biochemistry. 52: 1067-72. PMID 4609582  0.458
1974 Brazeau P, Vale W, Rivier J, Guillemin R. Acylated des-(Ala1-Gly2)-somatostatin analogs: prolonged inhibition of growth hormone secretion. Biochemical and Biophysical Research Communications. 60: 1202-7. PMID 4607622 DOI: 10.1016/0006-291X(74)90326-X  0.457
1974 Brazeau P, Vale W, Rivier J, Guillemin R. Biological potency of synthetic somatostatin in the oxidized and reduced form on the inhibition of secretion of growth hormone. Life Sciences. 15: 351-7. PMID 4549923 DOI: 10.1016/0024-3205(74)90225-2  0.49
1974 Gerich JE, Lorenzi M, Schneider V, Kwan CW, Karam JH, Guillemin R, Forsham PH. Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics. Diabetes. 23: 876-80. PMID 4430415 DOI: 10.2337/Diab.23.11.876  0.313
1974 Vale W, Rivier C, Brazeau P, Guillemin R. Effects of somatostatin on the secretion of thyrotropin and prolactin. Endocrinology. 95: 968-77. PMID 4213073 DOI: 10.1210/endo-95-4-968  0.658
1974 Siler TM, Yen SC, Vale W, Guillemin R. Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor. The Journal of Clinical Endocrinology and Metabolism. 38: 742-5. PMID 4207367 DOI: 10.1210/jcem-38-5-742  0.456
1974 Brazeau P, Guillemin R. Editorial: Somatostatin: newcomer from the hypothalamus. The New England Journal of Medicine. 290: 963-964. PMID 4206096 DOI: 10.1056/Nejm197404252901711  0.38
1974 Guillemin R. The hormones of the hypothalamus. Progress in Brain Research. 41: 117-32. PMID 4155518 DOI: 10.1016/S0079-6123(08)61903-2  0.382
1973 Siler TM, VandenBerg G, Yen SS, Brazeau P, Vale W, Guillemin R. Inhibition of growth hormone release in humans by somatostatin. The Journal of Clinical Endocrinology and Metabolism. 37: 632-4. PMID 4742541 DOI: 10.1210/jcem-37-4-632  0.529
1973 Blackwell R, Vale W, Rivier C, Guillemin R. Effect of perphenazine on the secretion of prolactin in vivo and in vitro. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 142: 68-71. PMID 4683266 DOI: 10.3181/00379727-142-36960  0.634
1973 Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science (New York, N.Y.). 179: 77-9. PMID 4682131 DOI: 10.1126/Science.179.4068.77  0.544
1973 Ling N, Rivier J, Burgus R, Guillemin R. Direct sequence determination of ovine luteinizing hormone releasing factor by mass spectrometry. Biochemistry. 12: 5305-10. PMID 4586516 DOI: 10.1021/Bi00750A013  0.378
1973 Guillemin R, Amoss M, Blackwell R, Burgus R, Grant G, Ling N, Monahan M, Rivier J, Vale W. Polypeptide antagonists of the hypothalamic luteinizing hormone releasing factors. Journal of Reproduction and Fertility. Supplement. 18: 23-30. PMID 4580254  0.494
1973 Rivier J, Vale W, Burgus R, Ling N, Amoss M, Blackwell R, Guillemin R. Synthetic luteinizing hormone-releasing factor analogs. Series of short-chain amide LRF homologs converging to the amino terminus. Journal of Medicinal Chemistry. 16: 545-9. PMID 4577979 DOI: 10.1021/Jm00263A031  0.462
1973 Blackwell R, Vale W, Amoss M, Burgus R, Monahan M, Rivier J, Ling N, Guillemin R. Lack of effect of native or synthetic LRF on secretion of prolactin in vitro. The American Journal of Physiology. 224: 176-9. PMID 4566850  0.421
1973 Blackwell R, Amoss M, Vale W, Burgus R, Rivier J, Monahan M, Ling N, Guillemin R. Concomitant release of FSH and LH induced by native and synthetic LRF. The American Journal of Physiology. 224: 170-5. PMID 4566849  0.462
1973 Burgus R, Ling N, Butcher M, Guillemin R. Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone. Proceedings of the National Academy of Sciences of the United States of America. 70: 684-8. PMID 4514982 DOI: 10.1073/Pnas.70.3.684  0.425
1973 Guillemin R, Vale W, Grant G. Chemistry of the hypothalamic releasing factors. Studies on structure-function relationships in TRF and LRF. Voprosy Biokhimii Mozga. 8: 141-76. PMID 4375346  0.423
1973 Vale W, Grant G, Guillemin R. Chemistry of the hypothalamic releasing factors--studies on structure-function relationships. Frontiers in Neuroendocrinology. 375-413. PMID 4369859  0.423
1973 Vale W, Blackwell R, Grant G, Guillemin R. TRF and thyroid hormones on prolactin secretion by rat anterior pituitary cells in vitro. Endocrinology. 93: 26-33. PMID 4351315 DOI: 10.1210/endo-93-1-26  0.517
1973 Blackwell RE, Guillemin R. Hypothalamic control of adenohypophysial secretions. Annual Review of Physiology. 35: 357-90. PMID 4350616 DOI: 10.1146/annurev.ph.35.030173.002041  0.335
1973 Rivier C, Vale W, Guillemin R. An in vivo corticotropin-releasing factor (CRF) assay based on plasma levels of radioimmunoassayable ACTH. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 142: 842-5. PMID 4348096 DOI: 10.3181/00379727-142-37129  0.624
1973 Burgus R, Vale W, Rivier J, Monahan M, Ling N, Grant G, Amoss M, Guillemin R. Chemistry of hypothalamic releasing factors. Progress in Brain Research. 39: 41-51. PMID 4208048 DOI: 10.1016/S0079-6123(08)64065-0  0.57
1973 Grant G, Vale W, Guillemin R. Characteristics of the pituitary binding sites for thyrotropin releasing factor. Endocrinology. 92: 1629-33. PMID 4196427 DOI: 10.1210/endo-92-6-1629  0.413
1973 Guillemin R. Hypothalamic Hormones: Releasing and Inhibiting Factors Hospital Practice. 8: 111-120. DOI: 10.1080/21548331.1973.11706765  0.427
1972 Vale W, Grant G, Amoss M, Blackwell R, Guillemin R. Culture of enzymatically dispersed pituitary cells: functional validation of a method. Endocrinology. 91: 562-72. PMID 4630101 DOI: 10.1210/endo-91-2-562  0.488
1972 Grant G, Vale W, Guillemin R. Interaction of thyrotropin releasing factor with membrane receptors of pituitary cells. Biochemical and Biophysical Research Communications. 46: 28-34. PMID 4621353 DOI: 10.1016/0006-291X(72)90625-0  0.472
1972 Guillemin R. Physiology and chemistry of the hypothalamic releasing factors for gonadotropins: a new approach to fertility control. Contraception. 5: 1-19. PMID 4568272 DOI: 10.1016/0010-7824(72)90076-5  0.414
1972 Guillemin R, Amoss M, Blackwell R, Rivier J, Ling N, Vale W. On the biological activities of the synthetic tetrapeptide pyroglutamyl-tyrosyl-arginyl-tryptophanyl-amide. Biochemical and Biophysical Research Communications. 48: 1093-9. PMID 4560003 DOI: 10.1016/0006-291X(72)90821-2  0.54
1972 Monahan MW, Rivier J, Vale W, Guillemin R, Burgus R. (Gly 2 )LRF and des-His 2 -LRF. The synthesis, purification, and characterization of two LRF analogues antagonistic to LRF. Biochemical and Biophysical Research Communications. 47: 551-6. PMID 4556826 DOI: 10.1016/0006-291X(72)90914-X  0.498
1972 Vale W, Grant G, Rivier J, Monahan M, Amoss M, Blackwell R, Burgus R, Guillemin R. Synthetic polypeptide antagonists of the hypothalamic luteinizing hormone releasing factor. Science (New York, N.Y.). 176: 933-4. PMID 4555980 DOI: 10.1126/science.176.4037.933  0.565
1972 Amoss M, Rivier J, Guillemin R. Release of gonadotropins by oral administration of synthetic LRF or a tripeptide fragment of LRF. The Journal of Clinical Endocrinology and Metabolism. 35: 175-7. PMID 4555782 DOI: 10.1210/jcem-35-1-175  0.331
1972 Yen SS, Rebar R, Van den Berg G, Naftolin F, Ehara Y, Engblom S, Ryan KJ, Benirschke K, Rivier J, Amoss M, Guillemin R. Synthetic luteinizing hormone-releasing factor. A potent stimulator of gonadotropin release in man. The Journal of Clinical Endocrinology and Metabolism. 34: 1108-11. PMID 4553517 DOI: 10.1210/jcem-34-6-1108  0.403
1972 Amoss M, Blackwell R, Guillemin R. Stimulation of ovulation in the rabbit triggered by synthetic LRF. The Journal of Clinical Endocrinology and Metabolism. 34: 434-6. PMID 4551071 DOI: 10.1210/jcem-34-2-434  0.309
1972 Burgus R, Butcher M, Amoss M, Ling N, Monahan M, Rivier J, Fellows R, Blackwell R, Vale W, Guillemin R. Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation). Proceedings of the National Academy of Sciences of the United States of America. 69: 278-82. PMID 4550508 DOI: 10.1073/PNAS.69.1.278  0.532
1972 Vale W, Brazeau P, Grant G, Nussey A, Burgus R, Rivier J, Ling N, Guillemin R. [Preliminary observations on the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone]. Comptes Rendus Hebdomadaires Des SéAnces De L'AcadéMie Des Sciences. SéRie D: Sciences Naturelles. 275: 2913-6. PMID 4347575  0.443
1972 Guillemin R, Burgus R. The hormones of the hypothalamus. Scientific American. 227: 24-33. PMID 4145789 DOI: 10.1038/Scientificamerican1172-24  0.441
1972 RIVIER J, MONAHAN M, VALE W, GRANT G, AMOSS M, BLACKWELL R, GUILLEMIN R, BURGUS R. ChemInform Abstract: FESTPHASEN-PEPTID-SYNTH. AN EINEM BENZHYDRYLAMIN-HARZ VON LRF (RELEASING-FAKTOR DES LUTEINISIERENDEN HORMONS) UND VON ANALOGEN EINSCHLIESSLICH ANTAGONISTEN Chemischer Informationsdienst. 3. DOI: 10.1002/chin.197238383  0.301
1971 Vale WW, Burgus R, Dunn TF, Guillemin R. In vitro plasma inactivation of thyrotropin releasing factor (TRF) and related peptides. Its inhibition by various means and by the synthetic dipeptide PCA-His-OME. Hormones. 2: 193-203. PMID 5006796 DOI: 10.1159/000178234  0.451
1971 Guillemin R, Burgus R, Vale W. The hypothalamic hypophysiotropic thyrotropin-releasing factor. Vitamins and Hormones. 29: 1-39. PMID 5002592 DOI: 10.1016/S0083-6729(08)60046-1  0.505
1971 Porter JC, Vale W, Burgus R, Mical RS, Guillemin R. Release of TSH by TRF infused directly into a pituitary stalk portal vessel. Endocrinology. 89: 1054-6. PMID 4999143 DOI: 10.1210/endo-89-4-1054  0.487
1971 Guillemin R, Amoss M, Blackwell R, Burgus R, Grant G, Ling N, Monahan M, Rivier J, Vale W. Polypeptides antagonists of the hypothalamic luteinizing hormone releasing factor. Gynecologic Investigation. 2: 2-12. PMID 4949825  0.328
1971 Amoss M, Burgus R, Blackwell R, Vale W, Fellows R, Guillemin R. Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor (LRF) of ovine origin. Biochemical and Biophysical Research Communications. 44: 205-10. PMID 4940370 DOI: 10.1016/S0006-291X(71)80179-1  0.435
1971 Guillemin R. Hypothalamic control of the secretion of adenohypophysial hormones. Advances in Metabolic Disorders. 5: 1-51. PMID 4326823 DOI: 10.1016/B978-0-12-027305-8.50021-7  0.389
1971 Desiderio DM, Burgus R, Dunn TF, Vale W, Guillemin R, Ward DN. The elucidation of the primary structure of the hypothalamic thyroid stimulating hormone releasing factor of ovine origin by means of mass spectrometry Organic Mass Spectrometry. 5: 221-228. DOI: 10.1002/oms.1210050212  0.507
1970 Fleischer N, Burgus R, Vale W, Dunn T, Guillemin R. Preliminary observations on the effect of synthetic thyrotropin releasing factor on plasma thyrotropin levels in man. The Journal of Clinical Endocrinology and Metabolism. 31: 109-12. PMID 4987499 DOI: 10.1210/jcem-31-1-109  0.478
1970 Vale W, Burgus R, Dunn TF, Guillemin R. Release of TSH by oral administration of synthetic peptide derivatives with TRF activity. The Journal of Clinical Endocrinology and Metabolism. 30: 148-50. PMID 4984011 DOI: 10.1210/jcem-30-1-148  0.449
1970 Burgus R, Dunn TF, Desiderio DM, Ward DN, Vale W, Guillemin R, Felix AM, Gillessen D, Studer RO. Biological activity of synthetic polypeptide derivatives related to the structure of hypothalamic TRF. Endocrinology. 86: 573-82. PMID 4983136 DOI: 10.1210/endo-86-3-573  0.434
1970 Burgus R, Guillemin R. Hypothalamic releasing factors. Annual Review of Biochemistry. 39: 499-526. PMID 4320674 DOI: 10.1146/annurev.bi.39.070170.002435  0.394
1969 Amoss MS, Guillemin R. Elevation of plasma LH concentrations induced by LH-releasing factor as measured by radioimmunoassay in the sheep. Endocrinology. 84: 1517-20. PMID 4889115 DOI: 10.1210/endo-84-6-1517  0.382
1969 Rodger NW, Beck JC, Burgus R, Guillemin R. Variability of response in the bioassay for a hypothalamic somatotrophin releasing factor based on rat pituitary growth hormone content. Endocrinology. 84: 1373-83. PMID 4889113 DOI: 10.1210/endo-84-6-1373  0.397
1968 Vale W, Burgus R, Guillemin R. On the Mechanism of Action of TRF: Effects of Cycloheximide and Actinomycin on the Release of TSH Stimulated in Vitro by TRF and its Inhibition by Thyroxine Neuroendocrinology. 3: 34-46. DOI: 10.1159/000121692  0.498
1967 Vale W, Burgus R, Guillemin R. Competition between thyroxine and TRF at the pituitary level in the release of TSH. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 125: 210-3. PMID 6028912 DOI: 10.3181/00379727-125-32051  0.452
1967 Davis TQ, Vale W, Guillemin R. Effects of Purified Thyrotropin Releasing Factor (TRF) on Thyrotropin (TSH) Release and Pituitary Acid Phosphatase Activity Neuroendocrinology. 2: 330-341. DOI: 10.1159/000121563  0.535
1967 Kastin AJ, Schally AV, Viosca S, Barrett L, Redding TW, D’Angelo SA, Hughes JS, Arai Y, Hiroi M, Mitra J, Gorski RA, Corbin A, Daniels EL, Davis TQ, Vale W, ... Guillemin R, et al. Contents, Vol. 2, 1967 Neuroendocrinology. 2. DOI: 10.1159/000121555  0.631
1966 Guillemin R, Ward DN, Sakiz E. Filtration chromatography on substituted Sephadex in the purification of the hypothalamic hormone TRF (TSH-releasing factor). Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 120: 256-8. PMID 5852723 DOI: 10.3181/00379727-120-30502  0.322
1964 SCHALLY AV, GUILLEMIN R. SOME BIOLOGICAL AND CHEMICAL PROPERTIES OF A LYSINE- VASOPRESSIN DIMER. The Journal of Biological Chemistry. 239: 1038-41. PMID 14165903  0.373
1963 GUILLEMIN R, SCHALLY AV. CONCENTRATION OF CORTICOTROPIN RELEASING FACTOR (CRF) IN ACID EXTRACTS OF SHEEP HYPOTHALAMUS BY GEL FILTRATION AND COUNTER CURRENT DISTRIBUTION. Texas Reports On Biology and Medicine. 21: 541-5. PMID 14087155  0.492
1963 SCHALLY AV, GUILLEMIN R. Isolation and chemical characterization of a beta-CRF from pig posterior pituitary glands. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 112: 1014-7. PMID 13976659  0.489
1962 SCHALLY AV, LIPSCOMB HS, LONG JM, DEAR WE, GUILLEMIN R. Chromatography and hormonal activities of dog hypothalamus. Endocrinology. 70: 478-80. PMID 14498007 DOI: 10.1210/endo-70-4-478  0.487
1962 SCHALLY AV, LIPSCOMB HS, GUILLEMIN R. Isolation and amino acid sequence of alpha2-corticotropin-releasing factor (alpha2-CRF) from hog pituitary glands. Endocrinology. 71: 164-73. PMID 14498006 DOI: 10.1210/endo-71-1-164  0.47
1962 SCHALLY AV, ROBINSON S, GUILLEMIN R. Quantitative aspects of percolation for the extraction of oxytocin and vasopressin. Texas Reports On Biology and Medicine. 20: 680-2. PMID 13976658  0.404
1962 GUILLEMIN R, SCHALLY AV, LIPSCOMB HS, ANDERSEN RN, LONG JM. On the presence in hog hypothalamus of 3-corticotropin releasing factor, alpha- and beta-melanocyte stimulating hormones, adrenocorticotropin, lysine-vasopressin and oxytocin. Endocrinology. 70: 471-7. PMID 13902822 DOI: 10.1210/endo-70-4-471  0.543
1961 GUILLEMIN R, SCHALLY AV. On the nature of the hypothalamic substance which controls the secretion of ACTH. Acta Neurovegetativa. 23: 58-62. PMID 13902823  0.474
1960 SCHALLY AV, GUILLEMIN R. Studies on corticotropin releasing factor: ion exchange chromotography of pituitary preparations. Texas Reports On Biology and Medicine. 18: 133-46. PMID 14442406  0.49
1960 SCHALLY AV, ANDERSEN RN, LONG JM, GUILLEMIN R. Isolation of alpha- and beta-melanocyte stimulating hormones (MSH) on a preparative scale. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 104: 290-3. PMID 14442404 DOI: 10.3181/00379727-104-25812  0.476
1960 SCHALLY AV, ANDERSEN RN, LIPSCOMB HS, LONG JM, GUILLEMIN R. Evidence for the existence of two corticotrophin-releasing factors, alpha and beta. Nature. 188: 192-3. PMID 13747238  0.492
1960 Schally AV, Andersen RN, Lipscomb HS, Long JM, Guillemin R. Evidence for the existence of two corticotrophin-releasing factors, α and ß Nature. 188: 1192-1193. DOI: 10.1038/1881192a0  0.339
1959 GUILLEMIN R, SCHALLY AV. Re-evaluation of a technique of pituitary incubation in vitro as an assay for corticotropin releasing factor. Endocrinology. 65: 555-62. PMID 13830170 DOI: 10.1210/endo-65-4-555  0.507
1959 SCHALLY AV, GUILLEMIN R. Concentration of corticotropin releasing factor by chromatography on carboxymethylcellulose. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 100: 138-9. PMID 13634063  0.504
1959 SCHALLY AV, LIPSCOMB HS, GUILLEMIN R. Chromatographic separation of oxytocin and vasopressin on carboxymethylcellulose. Biochimica Et Biophysica Acta. 31: 252-4. PMID 13628630  0.424
1953 HORAVA A, GUILLEMIN R, SELYE H. [Effect of Reichstein's compound L on certain effects from the administration of an anterior pituitary lobe extract]. Annales D'Endocrinologie. 14: 779-83. PMID 13138984  0.352
1952 GUILLEMIN R, SELYE H. [Nephrosclerotic and prophlogistic effect of various preparations of somatotropic hormones]. Annales D'Endocrinologie. 13: 836-40. PMID 13031204  0.444
Show low-probability matches.